BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3803064)

  • 1. [Therapeutic effect of small doses of bromocriptine on prolactinoma].
    Jin ZM; Shi YF; Gao SM
    Zhonghua Nei Ke Za Zhi; 1986 Aug; 25(8):475-8, 510. PubMed ID: 3803064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beneficial effect of Parlodel in a case of simultaneous prolactinoma and empty sella syndrome].
    Oó M; Deák G; Genszky K; Pintér E; Rábai K; Szalóczy P; Szilágyi G; Szücs K
    Orv Hetil; 1983 Dec; 124(51):3121-4. PubMed ID: 6657258
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
    Galvan G; Frick J; Irnberger T
    Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of pituitary prolactinoma with bromocriptine administration.
    Velentzas C; Carras D; Vassilouthis J
    JAMA; 1981 Mar; 245(11):1149-50. PubMed ID: 7463643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
    Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
    Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bromocriptine therapy of prolactinoma and hyperprolactinemia].
    Wu JZ
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):611-4. PubMed ID: 6673930
    [No Abstract]   [Full Text] [Related]  

  • 7. Continued growth of a large pituitary prolactinoma despite high dose bromocriptine.
    Bannister P; Sheridan P
    Br J Clin Pract; 1987 Apr; 41(4):712-3. PubMed ID: 3689652
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bromocriptine therapy in macroprolactinomas with extrasellar extension].
    Díaz de Greñu Martínez C; Menéndez Torre EL; Boix Pallarés P; Díaz Cadorniga FJ; Aller Granda J; Rabal Artal A
    Med Clin (Barc); 1988 Jan; 90(4):148-50. PubMed ID: 3352347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of prolactinoma with bromocriptine].
    Dtsch Med Wochenschr; 1983 Jan; 108(1):39. PubMed ID: 6848347
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine.
    Thorner MO; Perryman RL; Rogol AD; Conway BP; Macleod RM; Login IS; Morris JL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):480-3. PubMed ID: 7263835
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
    Katzir D; Rosenberg T; Ramot Y; Gaver-Shavit A; Gilboa Y
    Harefuah; 1990 Feb; 118(3):141-5. PubMed ID: 2341064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolactinoma and pregnancy].
    Katilolehti; 1982 Apr; 87(4):128-9. PubMed ID: 6920472
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term bromocriptine treatment of giant prolactinoma: report of a case].
    Mashio Y; Beniko M; Ikota A; Mizumoto H; Sato S; Yamaguchi O; Suzuki S; Tashiro T; Ikota T
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1785-6. PubMed ID: 2625603
    [No Abstract]   [Full Text] [Related]  

  • 15. Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
    Bergh T; Nillius SJ; Enoksson P; Wide L
    J Endocrinol Invest; 1984 Apr; 7(2):133-6. PubMed ID: 6725868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
    Landman L; Spindel A; Tal Y; Bar-Meir A; Sharf M; Dickstein G
    Harefuah; 1987 Oct; 113(7-8):156-9. PubMed ID: 3428740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolactinoma problem.
    Reichlin S
    N Engl J Med; 1979 Feb; 300(6):313-5. PubMed ID: 759885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of pituitary neoplasms].
    Kato Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Dec; 63(12):1429-38. PubMed ID: 2897313
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-existing prolactinoma with primary empty sella.
    Majeed PA; Saini JS; Dash RJ
    J Assoc Physicians India; 1985 Mar; 33(3):241-3. PubMed ID: 4044485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.